Drugmakers eager to satisfy shareholders are wheeling, dealing, and in one case even making trades like a pro sports team looking to shake up its roster.» Read More
The megabillion-dollar deals with Novartis also allow GlaxoSmithKline to "significantly expand" its world-leading vaccine business, GSK's CEO tells CNBC.
Pharmaceutical industry observers have been waiting for a rush of deals for months - and they might have finally arrived.
Obamacare or the Affordable Care Act offers insurance that is too costly, too complicated, and wrongly run by the government, say some who opt out.
Two of the world's largest pharmaceutical companies join forces, with GSK and Novartis agreeing to create a new consumer health-care business.
JPMorgan Chase's Mike Weinstein gives his top health care picks to buy right now, in light of recent weakness in the sector.
There are some solid reasons why Pfizer's reported $101 billion bid for AstraZeneca makes some sense, analysts said.
Activist investor William Ackman of Pershing Square Capital and Valeant Pharmaceuticals International are said to be pursuing a takeover of Allergan.
Biotech earnings kick off Tuesday after the bell as Gilead and Amgen report. Here's what to watch for.
Sarepta Therapeutics got the go-ahead to file for approval of its experimental drug for Duchenne muscular dystrophy.
U.S. pharmaceutical giant Pfizer has approached British rival AstraZeneca to propose a 60 billion pound takeover, Britain's Sunday Times reported.
HealthCare.gov warned enrollees that their passwords had been reset to guard against the "Heartbleed" bug.
Porcine epidemic diarrhea has killed millions of pigs in 27 states since showing up in the U.S. last May
Some medical groups now want doctors to consider both the effectiveness and costs of treatment options.
Enrollment in private Obamacare plans topped 8 million, the president announced Thursday.
California enrolled about 3.3 million in either private Obamacare plans or the state's version of Medicaid, officials announced Thursday.
This week the headline appeared to have some tough news for RNA companies, but Alnylam remains undeterred about the potential of its treatments.
According to a Gallup poll, Obamacare helped 10 million Americans to get new health insurance, making the percentage of insured people plummet.
UnitedHealth Group's earnings outlook will be limited, according to Citi analyst Carl McDonald, who downgraded shares of the nation's largest insurer to "neutral" from "buy."
New research shows insurers' efforts to entice healthy eating with coupons are paying off. But are the foods as healthy as the savings?
The effects of Obamacare will be difficult to measure as the Census Bureau is changing its annual survey. NYT reports.
Get the best of CNBC in your inbox